People who don’t respond to HIV meds overlooked by pharma, researchers

People who don’t respond to HIV meds overlooked by pharma, researchers

‘Left behind’: Drug companies and researchers have overlooked patients who don’t respond to HIV meds

By APOORVA MANDAVILLI

MIKE STARGHILL FOR STAT

Patient advocates are pursuing orphan drug status to give companies incentives to develop new treatments for people who don't respond to HIV therapies.

READ MORE